SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (3814)6/30/1998 6:18:00 PM
From: robert schiffer  Respond to of 9523
 
preliminary calculations. 2.0-2.5 million prescriptions. revenue of about 200 million at a minimum. bottom line approx. 65 million profit for the quarter or about 58 cents per share. monsterous compared to estimates. thank you media for allowing more time to accummulate. july 115 and august 115 calls look sweet.



To: Brander who wrote (3814)7/8/1998 5:55:00 PM
From: hilm  Respond to of 9523
 
Brad<<Most certainly, as this is less than the natural death rate. If more
people don't die with Viagra in their systems, then we have a very
wonderful medication that not only helps men with a problem that has
been very difficult to treat prior to Viagra, but also decreases the
death rate.>>

Brad,

Well said. I think PFE should get credit for actually lowering the deaths expected in that group.

hilm


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News